GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qualis Innovations Inc (OTCPK:QLIS) » Definitions » Debt-to-Equity

Qualis Innovations (Qualis Innovations) Debt-to-Equity : -0.02 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Qualis Innovations Debt-to-Equity?

Qualis Innovations's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.01 Mil. Qualis Innovations's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. Qualis Innovations's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-0.52 Mil. Qualis Innovations's debt to equity for the quarter that ended in Dec. 2023 was -0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Qualis Innovations's Debt-to-Equity or its related term are showing as below:

QLIS' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.02   Med: 0.06   Max: 0.14
Current: -0.02

During the past 9 years, the highest Debt-to-Equity Ratio of Qualis Innovations was 0.14. The lowest was -0.02. And the median was 0.06.

QLIS's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.21 vs QLIS: -0.02

Qualis Innovations Debt-to-Equity Historical Data

The historical data trend for Qualis Innovations's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qualis Innovations Debt-to-Equity Chart

Qualis Innovations Annual Data
Trend Jul06 Jul07 Jul08 Jul09 Jul10 Dec11 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only - 1.56 - 0.14 -0.02

Qualis Innovations Quarterly Data
Jul10 Oct10 Jan11 Apr11 Sep11 Dec11 Mar12 Jun12 Sep12 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 - - - -0.02

Competitive Comparison of Qualis Innovations's Debt-to-Equity

For the Medical Devices subindustry, Qualis Innovations's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qualis Innovations's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qualis Innovations's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Qualis Innovations's Debt-to-Equity falls into.



Qualis Innovations Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Qualis Innovations's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Qualis Innovations's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qualis Innovations  (OTCPK:QLIS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Qualis Innovations Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Qualis Innovations's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Qualis Innovations (Qualis Innovations) Business Description

Traded in Other Exchanges
N/A
Address
225 Wilmington West Chester Pike, Suite 200, No.145, Chadds Ford, PA, USA, 19317
Qualis Innovations Inc. is the holding company of mPathix Health, Inc. The company is focused on the development, production, and distribution of multi-modal pain management and Central Nervous System related solutions. It develops pain management products using a modality agnostic, virtual operating model. The company is developing a product designed to address the unmet needs of patients who seek alternatives to traditional pain medications and interventions or adjunctive therapies to their current treatment regimen.
Executives
Bin Wang director 112 RICO DR. NORTH, MORGANVILLE NJ 07751